Fund HoldingsAquilo Capital Management, LLC

Total Portfolio Value
$133.42M
Total Bought
$14.70M
Total Sold
$41.72M
Net Transaction
-$27.02M
Filing Period:
Securities
SharesValue ($K)
Q4 2023
Q1 2024
Change
Q4 2023
Q1 2024
Weight (%)
Change
PRECISION BIOSCIENCES INC0385,440+385,44005,2273.92%+5,227
SUTRO BIOPHARMA INC420,6491,165,466+744,8171,8056,5854.94%+4,780
REGENXBIO INC802,424906,248+103,82414,40419,09514.31%+4,691
MERUS N V355,109255,109-100,0009,76511,4888.61%+1,722
REPARE THERAPEUTICS INC633,271633,27104,6232,9832.24%-1,640
ARROWHEAD PHARMACEUTICALS IN(ARWR)908,474908,474027,79925,98219.47%-1,817
ARVINAS INC489,153405,766-83,38720,13416,75012.55%-3,384
SILENCE THERAPEUTICS PLC1,043,284574,214-469,07018,12212,4039.30%-5,719
BLUEPRINT MEDICINES CORP254,827182,151-72,67623,50517,27912.95%-6,226
KYMERA THERAPEUTICS INC(KYMR)881,337388,743-492,59422,43915,62711.71%-6,811
S&P BIOTECH ETF TR(Put)
ST STR SP BIOT
200,0000-200,00017,8580-17,858
Page 1 of 1